Epstein Secrets

lio Manager, ICS — U.S. ICS Investment Committee — Europe Brett Klein—EMD, Head of U.S. Corporate Credit Donald Young—MD, Senior Portfolio Manager,ICS - U.S. Ad eel Shafiqullah—MD, Senior Portfolio Manager, ICS - Europe Mathieu Clavel —MD, Head of European Corporate Credit Taj Sidhu—MD, Head of European

Successfully closed 12 U.S. CLOs with a total transaction value of approximately $7.0 billion Led by Brett Klein, Head of U.S. Corporate Credit, and Donald Young, Senior Portfolio Manager, Institutional Credit Strategies, with significant and broad expertise investing and managing loan, credit and CLO portfol

Risk Management Member of Partner Management Committee Brett KI eln—E MD, Head of U.S. Corporate Credit Donald Young—MD, Senior Portfolio Manager. ICS - U.S. ICS Investment Committee — Europe Brett Klein—E MD. Head of U.S. Corporate Credit Donald Young—MD, Senior Portfolio Manager, ICS- U.S. Admil Shaf

al Convertible and DerivativeArbitrage and Risk Management Member of Partner Management Committee Brett KI eln—E MD, Head of U.S. Corporate Credit Donald Young—MD, Senior Portfolio Manager. ICS - U.S. ICS Investment Committee — Europe Brett Klein—E MD. Head of U.S. Corporate Credit Donald Young—MD, Senior

Risk Management Member of Partner Management Committee Brett El eln—E MD, Head of U.S. Corporate Credit Donald Young—MD, Senior Portfolio Manager. ICS - U.S. ICS Investment Committee — Europe Brett Klein—E MD. Head of U.S. Corporate Credit Donald Young—MD, Senior Portfolio Manager, ICS- U.S. Admit Shaf

al Convertible and DerivativeArbitrage and Risk Management Member of Partner Management Committee Brett El eln—E MD, Head of U.S. Corporate Credit Donald Young—MD, Senior Portfolio Manager. ICS - U.S. ICS Investment Committee — Europe Brett Klein—E MD. Head of U.S. Corporate Credit Donald Young—MD, Senior